Task Force Guidance for Anxiety Screening Should Open a Series of Mental Health Support Doors

Task Force Guidance for Anxiety Screening Should Open a Series of Mental Health Support Doors

Sanjay Mathew, MD - ADAA President-Elect and Chief Medical Officer

Sanjay Mathew, MD - ADAA President-Elect and Chief Medical Officer

Sanjay J. Mathew, M.D. is the Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Vice Chair for Research and Professor in the Menninger Department of Psychiatry & Behavioral Sciences at Baylor College of Medicine. He is also a staff psychiatrist at the Michael E. Debakey VA Medical Center (MEDVAMC) in Houston, Texas. He graduated from Dartmouth College and Baylor College of Medicine, and trained in psychiatry at Columbia University and the New York State Psychiatric Institute, where he also completed a NIH-funded research fellowship in affective and anxiety disorders. Dr. Mathew began his faculty career at the Icahn School of Medicine at Mount Sinai where he co-founded and directed the Mood & Anxiety Disorders Program. In 2010, Dr. Mathew was recruited back to his hometown of Houston to direct Baylor’s Mood & Anxiety Disorders Program. His research program focuses on developing novel therapies for patients with treatment-resistant mood and anxiety disorders and PTSD, with a particular focus on rapid-acting glutamate-modulating agents. 

Dr. Mathew’s research program has been funded by NIMH, Department of Veterans Affairs, Patient-Centered Outcomes Research Institute (PCORI), and industry in the areas of experimental therapeutics and pathophysiology of treatment-resistant depression, suicide, and PTSD. He has authored or co-authored over 130 manuscripts and book chapters, and serves on the editorial board of several journals. In addition to his long involvement with ADAA including serving as Chair of the Program Committee (2017-2018), Dr. Mathew is a member of the American College of Neuropsychopharmacology, and board member of the American Society of Clinical Psychopharmacology. Dr. Mathew is ADAA Chief Medical Officer and Board Secretary. An active clinician and teacher, Dr. Mathew has been selected by his peers as a “Best Doctor” every year since 2011, and has received awards for his teaching of psychopharmacology.

"I am excited to have the opportunity to serve as President-Elect of ADAA, a professional membership organization truly committed to its education, practice, and research missions.   I look forward to collaborating with Dr. Simpson, the Board of Directors, and the ADAA staff to further strengthen the impact and reach of our organization for patients who suffer from these common and often debilitating conditions."   

Task Force Guidance for Anxiety Screening Should Open a Series of Mental Health Support Doors

Share
No
Task Force Guidance for Anxiety Screening Should Open a Series of Mental Health Support Doors

As the old adage goes, there’s a first time for everything. In the field of psychiatry, we are cautiously celebrating a recent first-time recommendation by the US Preventive Services Task Force calling on primary care providers to screen all adults under the age of 65 for anxiety. The independent, volunteer panel of medical experts influences national guidance for improving healthcare and makes evidence-based recommendations about clinical preventive services. For me and many of my colleagues, it is indeed a step in the right direction that the group has prioritized anxiety in primary care practice. This marks a sort of opening of the first door to those who suffer from anxiety or have a related disorder.  

Even before the pandemic, the United States was dealing, perhaps not so openly as now, with a pressing mental health crisis. This task force guidance brings to the forefront the need for more mental health screenings, something that we already knew in psychiatry, but what it also sheds light on is that the country has to find a way to keep up with demand. Everyone has anxiety – it’s part of being human. But the fact that anxiety has been recommended for screening may elevate its status to a medical symptom or condition that is worthy of further exploration. 

But like any explorer, the medical health professional conducting the screening needs the proper tools, resources, and support to move forward with the discovery. Unlike screening for hypertension or diabetes, detecting anxiety can be a lot more challenging, and getting a valid and reliable screening tool is essential. Other obstacles to consider are that the screening may give a false positive result or symptoms seemingly related to anxiety disorders can be transient and resolved with time or that self-reported information may not be totally accurate.   

So as my colleague and fellow ADAA member Dr. Luana Marques expressed in an article in MM+M, “Screening is a good idea but with the caveat of: what are we going to do once we screen?” Posing this question in today’s mental health environment is cause for anxiety itself. The number of mental health professionals to handle the current load of psychiatric conditions is insufficient as it is. What are we going to do when we get an influx of patients and we don’t have the clinicians, therapists, social workers or doctors to appropriately, fairly and efficiently treat them? This is particularly worrisome among ethnic, lower income, and BIPOC communities where demand is increasing faster than the supply of providers is capable of treating. As the laws of supply and demand suggest, we must find a way to balance the scales. 

I cannot agree more with Dr. Marques, a past president of the ADAA, who is adamant that a strained system must be accounted for and that we must work together as a field to help our patients. The idea of having a primary care professional officially screen for mental health issues or disorders opens the door but what about all the other doors after that?  We cannot keep closing them on our patients, especially when they are screened by their own medical providers and come to us for help. 

Dr. Marques has said that any enhanced screening should be accompanied by a standardized referral, giving patients a pathway to a clinician trained to handle anxiety. This requires a system of communication, partnering, additional training, collaboration, and a continuity of care that unfortunately does not exist as extensively as it should in the U.S. healthcare system. This is even more disconcerting in our mental health system.  

I believe that most of us in the mental health profession see this recommendation as an advancement. Some media sources have said the guidance couldn’t come at a worse time and likened it to a double-edged sword, but I like to think that a knife like that could cut through a lot of red tape and that the recommendation has come because it is needed. 

The next consideration or perhaps even guidance from all of us should be about how to tackle the workforce shortage issue and for that, I open the door to discussion. As we open these Pandora's boxes in mental health, remember that we are not creating problems that weren’t there or that we didn’t know existed; we are just releasing them to be dealt with.  For that, we need to think out of the box. 

Sanjay Mathew, MD - ADAA President-Elect and Chief Medical Officer

Sanjay Mathew, MD - ADAA President-Elect and Chief Medical Officer

Sanjay J. Mathew, M.D. is the Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Vice Chair for Research and Professor in the Menninger Department of Psychiatry & Behavioral Sciences at Baylor College of Medicine. He is also a staff psychiatrist at the Michael E. Debakey VA Medical Center (MEDVAMC) in Houston, Texas. He graduated from Dartmouth College and Baylor College of Medicine, and trained in psychiatry at Columbia University and the New York State Psychiatric Institute, where he also completed a NIH-funded research fellowship in affective and anxiety disorders. Dr. Mathew began his faculty career at the Icahn School of Medicine at Mount Sinai where he co-founded and directed the Mood & Anxiety Disorders Program. In 2010, Dr. Mathew was recruited back to his hometown of Houston to direct Baylor’s Mood & Anxiety Disorders Program. His research program focuses on developing novel therapies for patients with treatment-resistant mood and anxiety disorders and PTSD, with a particular focus on rapid-acting glutamate-modulating agents. 

Dr. Mathew’s research program has been funded by NIMH, Department of Veterans Affairs, Patient-Centered Outcomes Research Institute (PCORI), and industry in the areas of experimental therapeutics and pathophysiology of treatment-resistant depression, suicide, and PTSD. He has authored or co-authored over 130 manuscripts and book chapters, and serves on the editorial board of several journals. In addition to his long involvement with ADAA including serving as Chair of the Program Committee (2017-2018), Dr. Mathew is a member of the American College of Neuropsychopharmacology, and board member of the American Society of Clinical Psychopharmacology. Dr. Mathew is ADAA Chief Medical Officer and Board Secretary. An active clinician and teacher, Dr. Mathew has been selected by his peers as a “Best Doctor” every year since 2011, and has received awards for his teaching of psychopharmacology.

"I am excited to have the opportunity to serve as President-Elect of ADAA, a professional membership organization truly committed to its education, practice, and research missions.   I look forward to collaborating with Dr. Simpson, the Board of Directors, and the ADAA staff to further strengthen the impact and reach of our organization for patients who suffer from these common and often debilitating conditions."   

Use of Website Blog Commenting

ADAA Blog Content and Blog Comments Policy

ADAA provides this Website blogs for the benefit of its members and the public. The content, view and opinions published in Blogs written by our personnel or contributors – or from links or posts on the Website from other sources - belong solely to their respective authors and do not necessarily reflect the views of ADAA, its members, management or employees. Any comments or opinions expressed are those of their respective contributors only. Please remember that the open and real-time nature of the comments posted to these venues makes it is impossible for ADAA to confirm the validity of any content posted, and though we reserve the right to review and edit or delete any such comment, we do not guarantee that we will monitor or review it. As such, we are not responsible for any messages posted or the consequences of following any advice offered within such posts. If you find any posts in these posts/comments to be offensive, inaccurate or objectionable, please contact us via email at [email protected] and reference the relevant content. If we determine that removal of a post or posts is necessary, we will make reasonable efforts to do so in a timely manner.

ADAA expressly disclaims responsibility for and liabilities resulting from, any information or communications from and between users of ADAA’s blog post commenting features. Users acknowledge and agree that they may be individually liable for anything they communicate using ADAA’s blogs, including but not limited to defamatory, discriminatory, false or unauthorized information. Users are cautioned that they are responsible for complying with the requirements of applicable copyright and trademark laws and regulations. By submitting a response, comment or content, you agree that such submission is non-confidential for all purposes. Any submission to this Website will be deemed and remain the property of ADAA.

The ADAA blogs are forums for individuals to share their opinions, experiences and thoughts related to mental illness. ADAA wants to ensure the integrity of this service and therefore, use of this service is limited to participants who agree to adhere to the following guidelines:

1. Refrain from transmitting any message, information, data, or text that is unlawful, threatening, abusive, harassing, defamatory, vulgar, obscene, that may be invasive of another 's privacy, hateful, or bashing communications - especially those aimed at gender, race, color, sexual orientation, national origin, religious views or disability.

Please note that there is a review process whereby all comments posted to blog posts and webinars are reviewed by ADAA staff to determine appropriateness before comments are posted. ADAA reserves the right to remove or edit a post containing offensive material as defined by ADAA.

ADAA reserves the right to remove or edit posts that contain explicit, obscene, offensive, or vulgar language. Similarly, posts that contain any graphic files will be removed immediately upon notice.

2. Refrain from posting or transmitting any unsolicited, promotional materials, "junk mail," "spam," "chain mail," "pyramid schemes" or any other form of solicitation. ADAA reserves the right to delete these posts immediately upon notice.

3. ADAA invites and encourages a healthy exchange of opinions. If you disagree with a participant 's post or opinion and wish to challenge it, do so with respect. The real objective of the ADAA blog post commenting function is to promote discussion and understanding, not to convince others that your opinion is "right." Name calling, insults, and personal attacks are not appropriate and will not be tolerated. ADAA will remove these posts immediately upon notice.

4. ADAA promotes privacy and encourages participants to keep personal information such as address and telephone number from being posted. Similarly, do not ask for personal information from other participants. Any comments that ask for telephone, address, e-mail, surveys and research studies will not be approved for posting.

5. Participants should be aware that the opinions, beliefs and statements on blog posts do not necessarily represent the opinions and beliefs of ADAA. Participants also agree that ADAA is not to be held liable for any loss or injury caused, in whole or in part, by sponsorship of blog post commenting. Participants also agree that ADAA reserves the right to report any suspicions of harm to self or others as evidenced by participant posts.